/PRNewswire/ Shanghai LePure Biotech Co., Ltd. ("LePure") announced the completion of its Series C financing from a consortium of world-renowned investors.
LePure Biotech Closes Series C Financing Co-Led by Novo Holdings, General Atlantic, and Goldman Sachs Asset Management adnkronos.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from adnkronos.com Daily Mail and Mail on Sunday newspapers.
Doctor Anywhere, a regional tech-led healthcare company headquartered in Singapore, announced Wednesday that it has acquired Catalist-listed Asian Healthcare Specialists, an integrated healthcare provider in Singapore. The firm also announced a $38.8 million Series C1 financing round, an up round led by Novo Holdings, a Denmark-based international life science investor.
The company has also added Navjeewan Khosla from Novo Holdings as Board Observer.The company had announced a $50 million Series D investment led by Novo Holdings in August 2022.BANGALORE, India
/PRNewswire/ MedGenome, the leading genetic diagnostics, research, and data company in South Asia, announced today a $50 million investment led by Novo.